Nisa Investment Advisors
ANIK icon

Nisa Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

Nisa Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$609 Sell
42
-1,396
-97% -$16.2K ﹤0.01% 2835
2025
Q4 		$13.8K Buy
1,438
+1,397
+3,407% +$13.4K ﹤0.01% 2089
2025
Q3 		$385 Sell
41
-1,213
-97% -$11.6K ﹤0.01% 2885
2025
Q2 		$13.3K Buy
+1,254
New +$15.8K ﹤0.01% 2130
2025
Q1 		– Sell
-70
Closed -$1.15K – 2989
2024
Q4 		$1.15K Buy
70
+56
+400% +$1.1K ﹤0.01% 2648
2024
Q3 		$346 Sell
14
-375
-96% -$9.72K ﹤0.01% 2784
2024
Q2 		$9.85K Buy
389
+15
+4% +$389 ﹤0.01% 2157
2024
Q1 		$9.5K Buy
374
+10
+3% +$242 ﹤0.01% 2046
2023
Q4 		$8.25K Buy
364
+4
+1% +$83 ﹤0.01% 2073
2023
Q3 		$6.71K Sell
360
-26
-7% -$539 ﹤0.01% 2246
2023
Q2 		$10K Sell
386
-800
-67% -$21.4K ﹤0.01% 2257
2023
Q1 		$34K Hold
1,186
– – ﹤0.01% 1824
2022
Q4 		$35K Hold
1,186
– – ﹤0.01% 1878
2022
Q3 		$30K Buy
1,186
+26
+2% +$598 ﹤0.01% 1925
2022
Q2 		$26K Hold
1,160
– – ﹤0.01% 1964
2022
Q1 		$29K Buy
+1,160
New +$35.4K ﹤0.01% 1974
2021
Q4 		– Sell
-1,310
Closed -$56 – 2193
2021
Q3 		$56 Hold
1,310
– – ﹤0.01% 1909
2021
Q2 		$57 Hold
1,310
– – ﹤0.01% 1900
2021
Q1 		$53 Hold
1,310
– – ﹤0.01% 1968
2020
Q4 		$59K Buy
1,310
+150
+13% +$5.69K ﹤0.01% 1947
2020
Q3 		$41K Sell
1,160
-1,814
-61% -$65.5K ﹤0.01% 1867
2020
Q2 		$112K Buy
2,974
+334
+13% +$11K ﹤0.01% 1415
2020
Q1 		$76K Sell
2,640
-100
-4% -$4.04K ﹤0.01% 1440
2019
Q4 		$142K Hold
2,740
– – ﹤0.01% 1377
2019
Q3 		$150K Buy
2,740
+1,630
+147% +$83.7K ﹤0.01% 1390
2019
Q2 		$45K Hold
1,110
– – ﹤0.01% 1517
2019
Q1 		$34K Hold
1,110
– – ﹤0.01% 1557
2018
Q4 		$37K Sell
1,110
-2,900
-72% -$105K ﹤0.01% 1479
2018
Q3 		$169K Buy
4,010
+2,300
+135% +$90.9K ﹤0.01% 1343
2018
Q2 		$55K Hold
1,710
– – ﹤0.01% 1438
2018
Q1 		$89K Sell
1,710
-4,000
-70% -$226K ﹤0.01% 1367
2017
Q4 		$308K Sell
5,710
-1,000
-15% -$55.3K ﹤0.01% 1159
2017
Q3 		$389K Hold
6,710
– – ﹤0.01% 1099
2017
Q2 		$316K Hold
6,710
– – ﹤0.01% 1134
2017
Q1 		$291K Sell
6,710
-190
-3% -$9.07K ﹤0.01% 1166
2016
Q4 		$338K Sell
6,900
-3,000
-30% -$139K ﹤0.01% 1139
2016
Q3 		$474K Sell
9,900
-1,500
-13% -$74.1K 0.01% 1022
2016
Q2 		$612K Hold
11,400
– – 0.01% 918
2016
Q1 		$510K Hold
11,400
– – 0.01% 995
2015
Q4 		$435K Hold
11,400
– – 0.01% 994
2015
Q3 		$371K Buy
11,400
+3,000
+36% +$105K 0.01% 1056
2015
Q2 		$277K Hold
8,400
– – ﹤0.01% 1173
2015
Q1 		$346K Buy
8,400
+400
+5% +$16.2K ﹤0.01% 1138
2014
Q4 		$326K Sell
8,000
-1,500
-16% -$58.6K ﹤0.01% 1128
2014
Q3 		$348K Hold
9,500
– – ﹤0.01% 1108
2014
Q2 		$440K Sell
9,500
-2,000
-17% -$88.9K 0.01% 1073
2014
Q1 		$473K Buy
+11,500
New +$427K 0.01% 1043

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nisa Investment Advisors's ANIK Position: Q1 2026 in Review

Nisa Investment Advisors reduced its Anika Therapeutics (ANIK) stake by 97% in Q1 2026, selling an estimated $16.2K and leaving 42 shares worth $609. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

Nisa Investment Advisors first reported a position in ANIK in Q1 2014 and has held it in 47 quarters since. The position peaked at $612K in Q2 2016. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Nisa Investment Advisors held 42 shares of Anika Therapeutics worth $609 as of Q1 2026.
  • Nisa Investment Advisors sold 1,396 Anika Therapeutics shares in Q1 2026, an estimated $16.2K.
  • Anika Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2835 holding.
  • Nisa Investment Advisors first reported a position in Anika Therapeutics in Q1 2014 and has held it in 47 quarters since.
  • Nisa Investment Advisors's Anika Therapeutics position peaked at $612K in Q2 2016.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.